Nasaq Al Enjaz strengthens its position as a leading pharmaceutical distributor with new strategic partnerships and expanded service offerings across Saudi Arabia.
Riyadh, Saudi Arabia - Nasaq Al Enjaz is pleased to announce significant expansion plans for 2024, reinforcing its commitment to advancing healthcare accessibility across the Kingdom of Saudi Arabia.
## Strategic Growth Initiative
As part of our Vision 2030 alignment, Nasaq Al Enjaz has secured new partnerships with international pharmaceutical manufacturers, expanding our product portfolio to include cutting-edge treatments in oncology, diabetes management, and cardiovascular care.
## Enhanced Distribution Network
Our expanded distribution network now covers:
- **Northern Region**: Enhanced logistics hub in Qassim
- **Eastern Province**: New distribution center in Dammam
- **Southern Region**: Improved coverage in Abha and Jazan
## Quality Assurance Excellence
We continue to maintain the highest standards in:
- GDP (Good Distribution Practice) compliance
- Cold chain management for sensitive medications
- Real-time inventory tracking systems
- 24/7 quality monitoring
## Future Outlook
'This expansion represents our unwavering commitment to supporting Saudi Arabia's healthcare transformation,' said our CEO. 'We're not just distributing pharmaceuticals; we're delivering hope and healing to communities across the Kingdom.'
### Key Achievements 2024
- 📈 **40% increase** in distribution capacity
- 🏥 **200+ new healthcare partners** onboarded
- 🚚 **Next-day delivery** to 95% of KSA
- 🔬 **50+ new pharmaceutical products** in portfolio
For more information about our services, please contact our team at info@nasaq-sa.com.
Updated: Oct 10, 2024
Explore more news